(CMP) Compass Minerals - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US20451N1019

Salt, Chlorides, Potassium, Fertilizer, Retardant

CMP EPS (Earnings per Share)

EPS (Earnings per Share) of CMP over the last years for every Quarter: "2020-09": -0.07, "2020-12": 0.62, "2021-03": 0.96, "2021-06": -0.48, "2021-09": -0.14, "2021-12": 0.38, "2022-03": 0.33, "2022-06": -0.16, "2022-09": 0.01, "2022-12": -0.01, "2023-03": -0.46, "2023-06": 0.63, "2023-09": -0.06, "2023-12": 0.05, "2024-03": 1.49, "2024-06": -1.01, "2024-09": -1.01, "2024-12": -0.55, "2025-03": 0.63, "2025-06": -0.39, "2025-09": 0,

CMP Revenue

Revenue of CMP over the last years for every Quarter: 2020-09: 282.4, 2020-12: 421.1, 2021-03: 426, 2021-06: 199.4, 2021-09: 211.7, 2021-12: 331.5, 2022-03: 448.5, 2022-06: 214.7, 2022-09: 249.4, 2022-12: 352.4, 2023-03: 411.1, 2023-06: 207.6, 2023-09: 233.6, 2023-12: 341.7, 2024-03: null, 2024-06: 202.9, 2024-09: 208.8, 2024-12: 307.2, 2025-03: 494.6, 2025-06: 214.6, 2025-09: null,

Description: CMP Compass Minerals

Compass Minerals International Inc. (NYSE: CMP) is a diversified minerals producer operating in the United States, Canada, the United Kingdom, and other international markets. The company is organized into two primary business units – Salt and Plant Nutrition – and traces its corporate lineage back to 1844, with its headquarters in Overland Park, Kansas.

The Salt segment manufactures and sells a range of sodium chloride and magnesium chloride products, including rock salt, mechanically and solar-evaporated salt, and brine-derived magnesium chloride. It also purchases potassium chloride and calcium chloride for blending into specialty deicing formulations. End-uses span roadway deicing, consumer and professional ice-control products, chemical feedstock, water treatment, and animal nutrition, complemented by ancillary services such as records management.

The Plant Nutrition segment focuses on sulfate-of-potash (SOP) fertilizers sold under the Protassium⁺ brand, turf-grass products for golf courses and ornamental landscapes, organic fertilizer blends, and magnesium-chloride-based fire-retardant solutions. These products are distributed through crop-input retailers and sold directly to growers for broadcast, in-row, and liquid application methods.

Key performance indicators from the most recent fiscal year (2023) show total revenue of approximately $1.44 billion, with the Salt segment contributing roughly $950 million and Plant Nutrition about $490 million. EBITDA margin hovered near 15 %, reflecting relatively stable pricing in the deicing market but sensitivity to winter weather severity. Primary economic drivers include U.S. and Canadian winter precipitation patterns (which dictate deicing volumes), agricultural commodity cycles (corn and soybean planting acreage influencing SOP demand), and macro-level trends such as infrastructure spending on road maintenance and heightened regulatory focus on fertilizer runoff.

For a deeper quantitative assessment of CMP’s valuation and risk profile, you may find the ValueRay platform useful.

CMP Stock Overview

Market Cap in USD 784m
Sub-Industry Diversified Metals & Mining
IPO / Inception 2003-12-12

CMP Stock Ratings

Growth Rating -19.7%
Fundamental 42.3%
Dividend Rating 1.0%
Return 12m vs S&P 500 19.3%
Analyst Rating 4.0 of 5

CMP Dividends

Currently no dividends paid

CMP Growth Ratios

Growth Correlation 3m -54.7%
Growth Correlation 12m 61.4%
Growth Correlation 5y -91.4%
CAGR 5y -21.51%
CAGR/Max DD 3y (Calmar Ratio) -0.26
CAGR/Mean DD 3y (Pain Ratio) -0.42
Sharpe Ratio 12m -0.49
Alpha 32.85
Beta 1.571
Volatility 46.03%
Current Volume 332.8k
Average Volume 20d 381.4k
Stop Loss 17.1 (-6.6%)
Signal -0.75

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (-120.9m TTM) > 0 and > 6% of Revenue (6% = 73.5m TTM)
FCFTA 0.21 (>2.0%) and ΔFCFTA 38.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 24.93% (prev 36.38%; Δ -11.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.25 (>3.0%) and CFO 391.5m > Net Income -120.9m (YES >=105%, WARN >=100%)
Net Debt (761.2m) to EBITDA (72.9m) ratio: 10.44 <= 3.0 (WARN <= 3.5)
Current Ratio 2.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (41.9m) change vs 12m ago 1.20% (target <= -2.0% for YES)
Gross Margin 14.02% (prev 18.50%; Δ -4.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 78.22% (prev 61.80%; Δ 16.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.43 (EBITDA TTM 72.9m / Interest Expense TTM 70.3m) >= 6 (WARN >= 3)

Altman Z'' 0.89

(A) 0.20 = (Total Current Assets 570.6m - Total Current Liabilities 265.1m) / Total Assets 1.54b
(B) -0.05 = Retained Earnings (Balance) -70.4m / Total Assets 1.54b
(C) -0.02 = EBIT TTM -30.2m / Avg Total Assets 1.57b
(D) -0.13 = Book Value of Equity -166.6m / Total Liabilities 1.29b
Total Rating: 0.89 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 42.31

1. Piotroski 4.50pt = -0.50
2. FCF Yield 20.95% = 5.0
3. FCF Margin 26.42% = 6.61
4. Debt/Equity 3.37 = -1.29
5. Debt/Ebitda 10.44 = -2.50
6. ROIC - WACC (= -10.24)% = -12.50
7. RoE -45.37% = -2.50
8. Rev. Trend 8.72% = 0.65
9. EPS Trend -13.21% = -0.66

What is the price of CMP shares?

As of October 17, 2025, the stock is trading at USD 18.30 with a total of 332,765 shares traded.
Over the past week, the price has changed by -6.58%, over one month by +0.55%, over three months by -15.32% and over the past year by +36.98%.

Is Compass Minerals a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Compass Minerals (NYSE:CMP) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 42.31 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CMP is around 14.79 USD . This means that CMP is currently overvalued and has a potential downside of -19.18%.

Is CMP a buy, sell or hold?

Compass Minerals has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CMP.
  • Strong Buy: 1
  • Buy: 3
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CMP price?

Issuer Target Up/Down from current
Wallstreet Target Price 20 9.3%
Analysts Target Price 20 9.3%
ValueRay Target Price 16.3 -11.1%

Last update: 2025-10-06 02:04

CMP Fundamental Data Overview

Market Cap USD = 783.7m (783.7m USD * 1.0 USD.USD)
P/E Forward = 11.4548
P/S = 0.5175
P/B = 3.231
P/EG = 0.1337
Beta = 1.571
Revenue TTM = 1.23b USD
EBIT TTM = -30.2m USD
EBITDA TTM = 72.9m USD
Long Term Debt = 825.3m USD (from longTermDebt, last quarter)
Short Term Debt = 7.20m USD (from shortTermDebt, last quarter)
Debt = 840.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 761.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.54b USD (783.7m + Debt 840.6m - CCE 79.4m)
Interest Coverage Ratio = -0.43 (Ebit TTM -30.2m / Interest Expense TTM 70.3m)
FCF Yield = 20.95% (FCF TTM 323.7m / Enterprise Value 1.54b)
FCF Margin = 26.42% (FCF TTM 323.7m / Revenue TTM 1.23b)
Net Margin = -9.87% (Net Income TTM -120.9m / Revenue TTM 1.23b)
Gross Margin = 14.02% ((Revenue TTM 1.23b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 19.20% (prev 15.53%)
Tobins Q-Ratio = 1.00 (Enterprise Value 1.54b / Total Assets 1.54b)
Interest Expense / Debt = 1.94% (Interest Expense 16.3m / Debt 840.6m)
Taxrate = -25.0% (negative due to tax credits) (3.40m / -13.6m)
NOPAT = -37.8m (EBIT -30.2m * (1 - -25.00%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 2.15 (Total Current Assets 570.6m / Total Current Liabilities 265.1m)
Debt / Equity = 3.37 (Debt 840.6m / totalStockholderEquity, last quarter 249.8m)
Debt / EBITDA = 10.44 (Net Debt 761.2m / EBITDA 72.9m)
Debt / FCF = 2.35 (Net Debt 761.2m / FCF TTM 323.7m)
Total Stockholder Equity = 266.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.86% (Net Income -120.9m / Total Assets 1.54b)
RoE = -45.37% (Net Income TTM -120.9m / Total Stockholder Equity 266.5m)
RoCE = -2.77% (EBIT -30.2m / Capital Employed (Equity 266.5m + L.T.Debt 825.3m))
RoIC = -3.29% (negative operating profit) (NOPAT -37.8m / Invested Capital 1.15b)
WACC = 6.95% (E(783.7m)/V(1.62b) * Re(11.80%) + D(840.6m)/V(1.62b) * Rd(1.94%) * (1-Tc(-0.25)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.79%
[DCF Debug] Terminal Value 55.61% ; FCFE base≈323.7m ; Y1≈212.5m ; Y5≈97.2m
Fair Price DCF = 28.09 (DCF Value 1.17b / Shares Outstanding 41.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -13.21 | EPS CAGR: 0.35% | SUE: 0.37 | # QB: 0
Revenue Correlation: 8.72 | Revenue CAGR: -0.02% | SUE: 0.20 | # QB: 0

Additional Sources for CMP Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle